Study suggests asbestos cancer vaccine is safe
Mesothelioma Cancer News provides news and information for U.S. asbestos attorneys.
U.S. (Mesothelioma Cancer News) – New research suggests a vaccine being tested for the prevention of mesothelioma is safe. As reported by HealthDay News, the research is the first dendritic cell-based immunotherapy tested for patients with the asbestos-related cancer.
Dr. Joachim Aerts, a pulmonary physician at Erasmus Medical Center and author of the study, is quoted in the report as stating of the findings in a news release, “The possibility to harness the potency and specificity of the immune system underlies the growing interest in cancer immunotherapy… One such approach uses the patient’s own [dendritic cells] to present tumor-associated antigens and thereby generate tumor-specific immunity.”
More information about the study may be available in the March 4 online publication of the American Journal of Respiratory and Critical Care Medicine.
Online Mesothelioma News Legal News Distribution - mesotheliomacancernews.comOther News / Press Releases
- Mesothelioma is a Slow-Growing Cancer
- Hiring a Mesothelioma Lawyer
- What Are the Risk Factors for Mesothelioma Cancer?
- Make Choosing a Mesothelioma Attorney Your Top Priority
- Scientist Say Your Own Cells Could Be Triggering Mesothelioma
- Mother, Daughter Arrested for Obscene Facebook Video
- Report: War on Drugs is a Failure; Drug Reforms Urged
- U.S. Attorney General: New Law Will Give Crack Cocaine Offenders A Break
- Florida Governor Rick Scott Signs Welfare Drug-Screening Bill
- WHO: Cell phones are ‘Possibly Carcinogenic to Humans’



.png)





